Search Results

Now showing 1 - 6 of 6

Some of the metrics are blocked by your
consent settings
Ibervillea sonorae (S. Watson) Green a potential resource of bioactive compounds: Systematic analysis of a Mexican plant used in traditional medicine
(Elsevier, 2025)
Angulo Molina, Aracely
;
Cristofaro, Valeria di
;
Pieles, Uwe
;
López Romero, Julio César
;
Vidal Gutiérrez, Max
Ibervillea sonorae (S. Watson) Green (Cucurbitaceae) is a tuber succulent known as “wareke,” which grows in dry desert landscapes in northwestern Mexico and the southwestern United States. Indigenous tribes use I. sonorae as a remedy against cancer, inflammation, rheumatism, skin infections, and diabetes. The great popularity of wareke in traditional medicine has motivated various working groups to investigate its pharmacological properties. The antiproliferative, antitumoral, antifungal, hypoglycemic, antiinflammatory, antioxidant, and antimicrobial potential of this plant has been established. Chemical studies showed that I. sonorae is a potential resource of bioactive compounds, cucurbitacin-type triterpenoids, and phytosterols, the main secondary metabolites. The objective of this chapter is to systematically analyze the phytochemical knowledge of the plant (isolated and identified compounds), describe the biological activities of different extracts, isolated ingredients, and phytopreparations, and discuss their possible applications. ©The authors © 2025 Elsevier Inc.
Some of the metrics are blocked by your
consent settings
De-escalating treatment indications for patients who achieve metabolic goals
(Elsevier, 2024)
García-Ulloa, Ana Cristina
;
Jaime-Casas, Salvador
;
Rosado-Lozoya, Johanna S.
;
Serrano-Pérez, Nancy H.
;
Hernández-Juárez, Diana
Introduction: Robust evidence exists regarding initiation, intensification or modification of treatments. Recommendations to de-escalate therapy are lacking, specifically in diabetes. A successful treatment de-intensification reduces overtreatment, polypharmacy, and risk of adverse effects. Objective: To encompass current recommendations for deprescribing common drugs and create a consensus among health professionals. Methods: We reviewed four databases for deprescribing approaches published between 2010 and 2022. Articles were divided into different groups of drugs (for uric-acid, hypoglycemic, lipid-lowering, and psychotropic drugs).©Elsevier
16 1
Some of the metrics are blocked by your
consent settings
Logística para surtir medicamentos
(Hospitalidad ESDAI, 2018)
Espinoza, Pedro Pablo
;
Campus Ciudad de México
The lifestyle that currently prevails in the world involves situations that favor unhealthy conditions, which in turn leads to causes of the increases in incidence and mortality. Diabetes is a group of metabolic diseases characterized by high concentration of glucose in the blood and since 2000 the number of people with diagnosed diabetes has increased exponentially. On the other hand, diabetes in Mexico has also involved a high economic cost. The National Institute of Public Health indicates that 4.7% of government spending goes to this area.
3 71
Some of the metrics are blocked by your
consent settings
Estadística y cálculo vectorial en la economía de la salud en el sector público con respecto a la diabetes
(Hospitalidad ESDAI, 2017)
Pablo Espinosa, Pedro
;
Campus Ciudad de México
The resources to meet the epidemiological needs of the Mexican population are limited, so strategies are needed to improve the quality of life, through the allocation of these resources using analytical criteria that involve the effectiveness in the allocation of resources to improve the health status of the Mexican population.
2 51
Some of the metrics are blocked by your
consent settings
Diabetes: más común de lo que creemos. ¿Estamos preparados para dar un servicio adecuado a personas con diabetes?
(Hospitalidad ESDAI, 2008)
Sáinz de la Maza Viadero, María Elena
;
Campus Ciudad de México
In recent years diabetes has become a mayor health problem in Mexico, and has been catalogued, by some as a worldwide epidemic. At present, diabetes affects more than 246 million people in the word and it is expected to reach 333 million by 2025. Most cases are found in developing countries. This already tells us of the size of the problem. However, do we really know what diabetes is? Are we prepared to give an adequate service to people who live with this condition?
4 104
Some of the metrics are blocked by your
consent settings
El rostro pobre de la diabetes en México
(2018)
Ramírez Sánchez, José Carlos
;
Sota Riva, Marcela De la
This paper aims at modeling the dynamics of social deprivations (SD) of the Mexican poor population in order to differentiate their material living conditions in the presence or absence of diabetes mellitus 2 (DM2). The idea is to offer evidence on the influence of some community economic and social factors in the chain of causes conditioning the development of DM2 among the poor. For this purpose, we hypothesize that the probabilities of experiencing SD in the Mexican population are higher in individuals with DM2 depending on the type of localities, SD and clinical risk factors considered. The main results drawn from a hidden Markov model support the hypothesis that a part of the poor population, which is rural and diabetic, is the one with the highest probability (current and future) of experiencing sd in Mexico. ©2018 Universidad Nacional Autónoma de México.
Scopus© Citations 1 13 2

CRIS

Browse

Filters

Settings

Sort By

Results per page

Search Results